Skip to content

Comparison of the efficacy of topical agents treatment alone and in combination with Intense pulsed light in ocular rosacea and its mechanism exploration: a prospective randomized controlled study

Comparison of the efficacy of topical agents treatment alone and in combination with Intense pulsed light in ocular rosacea and its mechanism exploration: a prospective randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200063091
Enrollment
Unknown
Registered
2022-08-30
Start date
2022-08-31
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ocular rosacea

Interventions

Experimental group:erythromycin eye ointment in combination with Intense pulsed light
Control group:erythromycin eye ointment in combination with sham Intense pulsed light

Sponsors

Beijing University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Over 18 years old; 2. Definitely diagnosed as rosacea; 3. Diagnosis of meibomian gland dysfunction of grade 2 or above in both eyes, and the difference in grade of meibomian gland dysfunction in both eyes is <= 1 grade; 4. Volunteer to join this study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients who cannot see a doctor for a long time; 2. Other eye surgery or eye injury history within 6 months before the study; 3. Laser treatment around the eyes or face in the past 6 months; 4. Has a history of eye medication other than artificial tears and erythromycin eye ointment in the past 1 month; 5. IPL treatment contraindications (such as: previous history of facial herpes virus infection, pregnancy, epilepsy, etc.); 6. There are systemic diseases, including Sjogren's syndrome, graft-versus-host disease, Stevens-Johnson syndrome, and pemphigoid; 7. History of eye acid or alkali burns; 8. Wear contact lenses 48 hours before the test and during the study; 9. Implants under the treatment area; 10. There are tattoos in the treatment area; 11. Lactating or pregnant women; 12. Taking photosensitive drugs, such as isotretinoin, tetracycline or St. John's Wort; 13. Patients with eyelid abnormalities (such as entropion, ectropion, tumor, edema, blepharospasm, insufficiency of eyelid closure, trichiasis, ptosis, eyelid relaxation, etc.); 14. Glaucoma patients; 15. The researchers think that they are not suitable for inclusion.

Design outcomes

Primary

MeasureTime frame
Tear break-up time;

Countries

China

Contacts

Public ContactYan Xiaoming

Beijing University First Hospital

yanxiaoming7908@163.com+86 13501297605

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026